Radiopharmaceuticals represent a promising new frontier in cancer therapy. In the United States, cancer is the second leading cause of death. There is an urgent need to develop new therapies to meet ...

The second Society of Nuclear Medicine and Molecular Imaging (SNMMI) AI Summit, organized by the SNMMI AI Task Force, took ...

Incidental findings from PET are common, induce unnecessary patient anxiety, and incur substantial costs to the health care system, with further diagnostic clarification potentially delaying important ...

Recently, a collaborative effort among research centers in the United States and Europe resulted in the development of ...

Fibroblast activation protein (FAP) is highly expressed in many cancers, especially sarcomas, and represents a promising theranostic target. We present an updated retrospective analysis of 90Y-FAP ...

Radiopharmaceutical therapy (RPT) combined with external beam radiotherapy (EBRT) is emerging as a powerful approach in prostate cancer treatment. Historically rooted in early 89Sr trials, this ...

Journal of Nuclear Medicine December 2025, jnumed.125.270770; DOI: https://doi.org/10.2967/jnumed.125.270770 ...

Journal of Nuclear Medicine December 2025, jnumed.125.271103; DOI: https://doi.org/10.2967/jnumed.125.271103 ...

Journal of Nuclear Medicine July 2025, jnumed.125.269653; DOI: https://doi.org/10.2967/jnumed.125.269653 ...

Journal of Nuclear Medicine June 2025, jnumed.125.269655; DOI: https://doi.org/10.2967/jnumed.125.269655 ...

Journal of Nuclear Medicine June 2025, 66 (supplement 1) 252173; ...

The study of the human phenome is essential for understanding the complexities of wellness and disease and their transitions, with molecular imaging being a vital tool in this exploration. Molecular ...